A new technology advance has led to the introduction of new actuators that combine motor, drive, gearing, and feedback into a single CANopen device that relieves much of the burden of traditional ...
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001) ...